AstraZeneca could leave the London Stock Exchange over dissatisfaction with regulations, which would significantly affect the FTSE 100 index.
Sanziana Georgescu
Economy
sursa foto: unsplash.com
Always see our news on Google
British pharmaceutical company AstraZeneca, with a market capitalization of £161.2 billion, is considering a move to the US stock exchange because of dissatisfaction with UK regulations. The decision could reflect a wider trend in which companies prefer US markets for higher valuations and a bigger investor base. Experts believe AstraZeneca's departure would be a significant loss for the London Stock Exchange, which risks losing its status as a global financial center.
Sources
Latest News
11:17
The number of deaths resulting from the earthquakes in Venezuela has risen to 6,125. Almost 1,400 people are reported missing.
11:15
Romanian firefighters return from the mission to extinguish fires in France / The third shift of the module continues missions in support of the French authorities
11:12
The Prosumers Association requests the application of 0% VAT for photovoltaic systems up to 27 kW and storage batteries.
11:05
The National Meteorological Administration extends heat alerts: Red code in several counties across the country / Temperatures up to 41 degrees
11:05
The former commander of the Ukrainian army criticized NATO for its lack of adaptation to modern warfare and questioned the prospect of Ukraine's membership.
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
